Elsevier Inc.

SHERPA: Unknown

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Dahi
    Dahi
  4. Shah
    Shah
  5. Papanicolaou
    Papanicolaou
  6. Boelens
    Boelens
  7. Lin
    Lin
  8. Politikos
    Politikos
  9. Ponce
    Ponce
  10. Scordo
    Scordo

Groups

  1. Department of Medicine (152)
  2. Hematologic Malignancies, Division of (127)
  3. Center for Hematologic Malignancies (121)
  4. Bone Marrow Transplant (110)
  5. CTCR Scholars (55)
  6. Pediatrics, Department of (49)
  7. Survivorship Research (46)
  8. MSK Grad Students (43)
  9. Stem Cell Transplantation and Cellular Therapy Service (43)
  10. Master of Science in Clinical and Translational Cancer Research (42)
Search Within
  1. "Transplantation and Cellular Therapy"
Formats
  1. Journal Article (85)
  2. Meeting Abstract (53)
  3. Guidelines (31)
  4. Review (15)
  5. Editorial (13)
Groups
  1. Department of Medicine (152)
  2. Hematologic Malignancies, Division of (127)
  3. Center for Hematologic Malignancies (121)
  4. Bone Marrow Transplant (110)
  5. CTCR Scholars (55)
  6. Pediatrics, Department of (49)

More Groups

People
  1. Miguel-Angel Perales (66)
  2. Sergio Giralt (36)
  3. Parastoo Dahi (25)
  4. Sean Devlin (25)
  5. Gunjan Shah (23)
  6. Genovefa Papanicolaou (21)

More People

Years
  1. 2025 (16)
  2. 2024 (28)
  3. 2023 (31)
  4. 2022 (82)
  5. 2021 (40)
Publications
  1. Transplantation and Cellular Therapy (197)

Results (197)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quality-adjusted time without symptoms or toxicity: Analysis of axicabtagene ciloleucel versus standard of care in patients with relapsed/refractory large B cell lymphoma
    Journal Article

    Kersten, M. J.; Qiao, Y.; Shah, R.; Solem, C.; Snider, J. T.; To, C.; Cheng, P.; Spooner, C.; Perales, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Frequently asked questions about Mpox (formerly Monkeypox disease) for hematopoietic cell transplantation and chimeric antigen receptor T cell recipients from the American Society for Transplantation and Cellular Therapy
    Review

    Ford, E. S.; Papanicolaou, G. A.; Dadwal, S. S.; Pergam, S.; Spallone, A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • An optimized search prognosis tool to predict 8/8 HLA allele-matched unrelated donor procurement
    Journal Article

    Davis, E.; Archer, A.; Flynn, J.; Nhaissi, M.; Rapoport, C.; Suri, B.; Wells, D.; Papadopoulos, E.; Politikos, I.; Fingrut, W. B.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • T-cells: Third party parity for viral infections
    Editorial

    O'Reilly, R. J.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Systematic review of signs and symptoms associated with hematopoietic stem cell transplantation-associated thrombotic microangiopathy
    Review

    Dandoy, C. E.; Tsong, W. H.; Sarikonda, K.; McGarvey, N.; Perales, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Ethical challenges with multiple myeloma BCMA chimeric antigen receptor T cell slot allocation: A multi-institution experience
    Journal Article

    Kourelis, T.; Bansal, R.; Berdeja, J.; Siegel, D.; Patel, K.; Mailankody, S.; Htut, M.; Shah, N.; Wong, S. W.; Sidana, S.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Paving the road for chimeric antigen receptor T cells: American Society for Transplantation and Cellular Therapy 80/20 task force consensus on challenges and solutions to improving efficiency of clinical center certification and maintenance of operations for commercially approved immune effector cell therapies
    Journal Article

    Nikiforow, S.; Frigault, M. J.; Frey, N. V.; Gardner, R. A.; Komanduri, K. V.; Perales, M. A.; Kebriaei, P.; Warkentin, P. I.; Pasquini, M.; Aho, J. L.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • American Society for Transplantation and Cellular Therapy series, #6: Management of invasive candidiasis in hematopoietic cell transplantation recipients
    Guidelines

    Neofytos, D.; Steinbach, W. J.; Hanson, K.; Carpenter, P. A.; Papanicolaou, G. A.; Slavin, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: Follow-up from a national marrow donor program-sponsored prospective clinical trial
    Journal Article

    Shaw, B. E.; Jimenez-Jimenez, A. M.; Burns, L. J.; Logan, B. R.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save